Literature DB >> 25066038

Follicular lymphoma grade 3: review and updates.

Gayatri Vaidyanathan1, Myron S Czuczman2.   

Abstract

Follicular lymphoma (FL), Grade 3, is recognized as a distinct entity in the World Health Organization classification of lymphoma. It is further classified into Grade 3a and Grade 3b depending on the Bernard cell counting system and percentage of centroblasts. Grade 3 has molecular and genetic characteristics that distinguish it from other grades of FL. There is confusion and misunderstanding about the natural history and clinical course of Grade 3a and 3b because some studies indicate them as having indolent behavior and others describe more aggressive biology. The purpose of this article is to understand the concept of Grade 3 FL, especially the fundamental differences between Grade 3a and Grade 3b FL. Grade 3 FL is still an evolving subclass in FL and the practicing physician should understand the aggressive nature of Grade 3b, which typically requires timely attention, compared with Grade 3a. Grade 3a FL has more indolent characteristics but can possibly progress to Grade 3b and/or transform to diffuse large B-cell lymphoma at a future time. Nevertheless, large prospective studies are missing for an optimal evidence-based management approach for patients with Grade 3 FL at this time.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  B-cell lymphoma; Follicular lymphoma grade 3a; Follicular lymphoma grade 3b; Grade 3 follicular lymphoma; Indolent lymphoma

Mesh:

Year:  2014        PMID: 25066038     DOI: 10.1016/j.clml.2014.04.008

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma Leuk        ISSN: 2152-2669


  5 in total

1.  Grade 3A follicular lymphoma can be effectively controlled with very low-dose radiation therapy.

Authors:  Brandon S Imber; Karen Chau; Eliana Goldberg; Erel Joffe; Joachim Yahalom
Journal:  Leuk Lymphoma       Date:  2020-02-09

Review 2.  Follicular Lymphoma: a Focus on Current and Emerging Therapies

Authors:  Kirk E Cahill; Sonali M Smith
Journal:  Oncology (Williston Park)       Date:  2022-02-08       Impact factor: 2.533

3.  A Favorable Outcome of Grade 3 Follicular Lymphoma Treated With Surgery and Obinutuzumab Combined With Chemotherapy: A Case Report and Literature Review.

Authors:  Erinie Mekheal; Brooke E Kania; Sherif Roman; Nader Mekheal; Vinod Kumar; Leena Bondili; Michael Maroules
Journal:  Cureus       Date:  2022-03-29

4.  Prediction of prognosis and pathologic grade in follicular lymphoma using 18F-FDG PET/CT.

Authors:  Hongyan Li; Min Wang; Yajing Zhang; Fan Hu; Kun Wang; Chenyang Wang; Zairong Gao
Journal:  Front Oncol       Date:  2022-07-28       Impact factor: 5.738

5.  [Clinical characteristics and survival analysis of de novo grade 3 or transformed follicular lymphoma patients].

Authors:  Z T Ying; H Y Feng; L Mi; Y Q Song; X P Wang; W Zheng; N J Lin; M F Tu; Y Xie; L Y Ping; C Zhang; W P Liu; L J Deng; J Zhu
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2018-09-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.